V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression (Q31867024)

4 July 2017

title

V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression (English)

1 reference

4 July 2017

1 reference

Narod SA

1 reference

4 July 2017

Nam RK

1 reference

4 July 2017

Toi A

1 reference

4 July 2017

Vesprini D

1 reference

4 July 2017

Ho M

1 reference

4 July 2017

Chu W

1 reference

4 July 2017

Harvie S

1 reference

4 July 2017

Sweet J

1 reference

4 July 2017

Trachtenberg J

1 reference

4 July 2017

Jewett MA

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

4 July 2017

1 reference

4 July 2017

1 reference

4 July 2017

1 reference

4 July 2017

page(s)

199-204

1 reference

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900928-6

7 January 2021

Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900928-6

7 January 2021

The impact of family history on early detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900928-6

7 January 2021

Prospective study of sex hormone levels and risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900928-6

7 January 2021

Effect of the dual 5alpha-reductase inhibitor PNU 157706 on the growth of dunning R3327 prostatic carcinoma in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900928-6

7 January 2021

Effect of early treatment of prostate cancer with the 5alpha-reductase inhibitor turosteride in Dunning R3327 prostatic carcinoma in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900928-6

7 January 2021

A five-alpha reductase inhibitor or an antiandrogen prevents the progression of microscopic prostate carcinoma to macroscopic carcinoma in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900928-6

7 January 2021

Natural Mutagenesis Study of the Human Steroid 5.alpha.-Reductase 2 Isoenzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900928-6

7 January 2021

Brief report: the molecular basis of steroid 5 alpha-reductase deficiency in a large Dominican kindred

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900928-6

7 January 2021

Response of rat and human prostatic cancers to the novel 5 alpha-reductase inhibitor, SK&F 105657

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900928-6

7 January 2021

Genetic linkage mapping of the human steroid 5 alpha-reductase type 2 gene (SRD5A2) close to D2S352 on chromosome region 2p23-->p22

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900928-6

7 January 2021

Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900928-6

7 January 2021

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900928-6

7 January 2021

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900928-6

7 January 2021

Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900928-6

7 January 2021

Information on death certificates: cause for concern?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900928-6

7 January 2021

Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900928-6

7 January 2021

Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900928-6

7 January 2021

The value of serum prostate specific antigen determinations before and after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900928-6

7 January 2021

10.1016/S0090-4295(00)00928-6

Identifiers

DOI

1 reference

4 July 2017

1 reference